RPS19P3

Across TCGA pan-cancer cohorts, RPS19P3 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RPS19P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS19P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS19P3 is over-expressed in tumor.

COAD, STAD, and LUAD are the cancer types where RPS19P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS19P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+2.185	<.001	11	view →
STAD	All	IV	+1.169	<.001	9	view →
LUAD	Female	All	+0.729	<.001	8	view →
KIRC	Male	All	+0.513	<.001	8	view →
LIHC	All	II,III,IV	+0.402	<.001	7	view →
LUSC	All	All	+0.465	<.001	6	view →
HNSC	Male	All	+0.338	.009	5	view →
CHOL	Male	All	+1.265	<.001	4	view →
READ	All	All	+1.073	.001	3	view →
ESCA	Male	All	+1.005	.002	2	view →
PRAD	All	All	+0.193	.034	2	view →
BLCA	Female	IV	+1.103	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RPS19P3–COAD

Open the COAD breakdown →